CompletedNot Applicable

Diagnostic Breath Analysis for Detection of Ventilator Acquired Pneumonia (VAP)

United States10 participantsStarted 2016-10

Plain-language summary

Breath samples from patients with Ventilator Acquired Pneumonia (VAP) will be analyzed to identify Volatile Organic Compounds (VOC) that have been specifically associated with VAP in previous animal models. Primary outcome measures will include the assessment of the zNose Diagnostic Breath Analysis System in the early detection of VOC's associated with VAP.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Three or more positive out of the following:
✓. Tympanic temperature \> 38 °C or \< 35.5 °C
✓. Blood leukocytosis (10,000/µl)
✓. More than ten leukocytes in Gram stain of tracheal aspirate (in high-flow field)
✓. Positive culture of tracheal aspirate
✓. New, persistent, or progressive infiltrate on chest radiograph

What they're measuring

Diagnostic Breath Analysis

Timeframe: 6 months

Trial details

NCT IDNCT03053258

SponsorLandon Pediatric Foundation

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2018-10

View on ClinicalTrials.gov More Bacterial Infections trials